The Cooper Companies, Inc. (NYSE:COO) reported Q3 results, with EPS of $3.41, which beat the consensus estimate of $3.30. Quarterly revenue came in at $763.4 million, 5.36% better than the Street estimate.
For the full 2021-year, the company expects total revenue to range from $2.89 billion to $2.92 billion, above the consensus estimate of $2.87 billion.
The company saw 16% growth in the Americas region seeing a continued improvement in patient flow, EMEA (growing 24%) captured market share and saw consumer activity return, and APAC (growing 18%) consumer activity remain somewhat muted, though continues to rebound led by steady improvements.
Analysts at Oppenheimer raised their price target on the company to $475 from $405. While competition in the contact lens market remains stiff, the brokerage estimates above-market contact lens growth for the company driven by its specialty lens offerings and by increased silicone hydrogel daily penetration.
Symbol | Price | %chg |
---|---|---|
7741.T | 20595 | 0 |
OMED.JK | 186 | 0 |
4543.T | 2689.5 | 0 |
MARK.JK | 910 | 0 |